Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia

Infection

Volumn 40, Issue 1, 2012, Pages 81-85

  Bjorkholm M ^a   Kalin, M ^a   Grane, P ^a   Celsing, F ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMSACRINE; BETAMETHASONE; CASPOFUNGIN; CEFTAZIDIME; CLIOQUINOL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MERCAPTOPURINE; MEROPENEM; METHOTREXATE; MOXIFLOXACIN; POSACONAZOLE; TETRACYCLINE; VANCOMYCIN; VINCRISTINE; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRANULOCYTOPENIA; HALLUCINATION; HUMAN; INVASIVE ASPERGILLOSIS; LARYNGOTRACHEOBRONCHITIS; LONG TERM CARE; LUNG ASPERGILLOSIS; MALE; PNEUMOCYSTIS PNEUMONIA; POLYNEUROPATHY; REMISSION; ROSACEA; SIDE EFFECT; SINUSITIS; TRACHEOBRONCHITIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BRAIN; CEREBRUM; ECHINOCANDINS; HUMANS; LARYNX; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROASPERGILLOSIS; PARANASAL SINUSES; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PULMONARY ASPERGILLOSIS; PYRIMIDINES; SWEDEN; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 84857792588     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0158-9     Document Type: Article

References (16)

1. T Fukuda M Boeckh RA Carter BM Sandmaier MB Maris DG Maloney, et al. 2003 Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning Blood 102 827 833 12689933 10.1182/blood-2003-02-0456 1:CAS:528:DC%2BD3sXlvFCmsLs%3D (Pubitemid 36917771)
2. L Pagano M Caira A Candoni M Offidani L Fianchi B Martino, et al. 2006 The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study Haematologica 91 1068 1075 16885047 (Pubitemid 44208634)
3. Y Nivoix M Velten V Letscher-Bru A Moghaddam S Natarajan-Amé C Fohrer, et al. 2008 Factors associated with overall and attributable mortality in invasive aspergillosis Clin Infect Dis 47 1176 1184 18808352 10.1086/592255
4. TJ Walsh EJ Anaissie DW Denning R Herbrecht DP Kontoyiannis KA Marr, et al. 2008 Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America Clin Infect Dis 46 327 360 18177225 10.1086/525258 1:CAS:528:DC%2BD1cXitlKqt7c%3D (Pubitemid 351265310)
5. OA Cornely 2008 Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections Infection 36 296 313 18642109 10.1007/s15010-008-7357-z 1:CAS:528:DC%2BD1cXhtV2lsrjI
6. RY Hachem MR Boktour HA Hanna R Husni EY Hanna X Keutgen, et al. 2008 Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer Infection 36 539 542 18726553 10.1007/s15010-008-7388-5 1:STN:280:DC%2BD1M%2Fos1Onsg%3D%3D
7. SJ Lin J Schranz SM Teutsch 2001 Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358 366 11170942 10.1086/318483 1:STN:280:DC%2BD38%2Fgs12lsg%3D%3D (Pubitemid 32173620)
8. S Gallien S Fournier R Porcher J Bottero P Ribaud A Sulahian, et al. 2008 Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases Infection 36 533 538 19011743 10.1007/s15010-008-7375-x 1:STN:280:DC%2BD1M%2Foslakuw%3D%3D
9. L Pagano M Caira P Falcucci L Fianchi 2005 Fungal CNS infections in patients with hematologic malignancy Expert Rev Anti Infect Ther 3 775 785 16207169 10.1586/14787210.3.5.775 (Pubitemid 41535399)
10. A Pascual T Calandra S Bolay T Buclin J Bille O Marchetti 2008 Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Clin Infect Dis 46 201 211 18171251 10.1086/524669 1:CAS:528:DC%2BD1cXhvVClsbY%3D (Pubitemid 351269158)
11. http://www.sfhem.se/main.shtml.
12. S Schwartz E Thiel 2009 Cerebral aspergillosis: tissue penetration is the key Med Mycol 47 Suppl 1 S387 S393 19255905 10.1080/13693780802537953 1:CAS:528:DC%2BD1MXms1Ons7o%3D
13. Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011. [Epub ahead of print].
14. SL Gerson GH Talbot S Hurwitz BL Strom EJ Lusk PA Cassileth 1984 Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann Intern Med 100 345 351 6696356 1:STN:280:DyaL2c7is1ehsw%3D%3D (Pubitemid 14156535)
15. S Tsiodras R Zafiropoulou E Kanta C Demponeras N Karandreas EK Manesis 2005 Painful peripheral neuropathy associated with voriconazole use Arch Neurol 62 144 146 15642862 10.1001/archneur.62.1.144 (Pubitemid 40105048)
16. F Aksoy E Akdogan K Aydin M Yilmaz V Altunayoglu EE Sozen, et al. 2008 Voriconazole-induced neuropathy Chemotherapy 54 224 227 18560230 10.1159/000140466 1:CAS:528:DC%2BD1cXnvFeiuro%3D (Pubitemid 351929274)